Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine in thoracoscopic lung surgery: effects on ventilated lung exhaled condensate inflammation
ChiCTR2100042622Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in lung neoplasm and postoperative pulmonary inflammation (PPI) (2 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoint: Inflammatory factors and oxidative stress indicators in exhaled breath condensate of ventilated lung. Started Mar 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
lung neoplasmpostoperative pulmonary inflammation (PPI)
Beyond the preview
Go deeper on ChiCTR2100042622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042622.